Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-CD20/CD47 tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Lymphoma therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD20 x Anti-CD47 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-052). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS